Because agammaglobulinemic patients show a markedly increased incidence of a rheumatoid‐like arthritis, which improves after γ globulin treatment, the clinical and serological changes resulting from repeated injections of pooled human γ globulin given to adult patients with rheumatoid arthritis have been evaluated in a controlled, double‐blind study. No significant beneficial effects on laboratory or clinical parameters were observed. However, 2 of the 10 patients treated developed precipitating antibody to a β globulin component of the γ globulin preparation given.